These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 22219230

  • 1. Q: Should target natriuretic peptide levels be used for outpatient management of chronic heart failure?
    Ibrahim A, Baibars M, Alraies MC, Oliveira GH.
    Cleve Clin J Med; 2012 Jan; 79(1):22-5. PubMed ID: 22219230
    [No Abstract] [Full Text] [Related]

  • 2. Biomarker-guided treatment of heart failure: still waiting for a definitive answer.
    Troughton RW, Frampton CM, Nicholls MG.
    J Am Coll Cardiol; 2010 Dec 14; 56(25):2101-4. PubMed ID: 21144970
    [No Abstract] [Full Text] [Related]

  • 3. Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study.
    Eurlings LW, van Pol PE, Kok WE, van Wijk S, Lodewijks-van der Bolt C, Balk AH, Lok DJ, Crijns HJ, van Kraaij DJ, de Jonge N, Meeder JG, Prins M, Pinto YM.
    J Am Coll Cardiol; 2010 Dec 14; 56(25):2090-100. PubMed ID: 21144969
    [Abstract] [Full Text] [Related]

  • 4. Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure.
    Braunschweig F, Fahrleitner-Pammer A, Mangiavacchi M, Ghio S, Fotuhi P, Hoppe UC, Linde C.
    Eur J Heart Fail; 2006 Dec 14; 8(8):797-803. PubMed ID: 16716660
    [Abstract] [Full Text] [Related]

  • 5. NT-proBNP and BNP: biomarkers for heart failure management.
    Bettencourt P.
    Eur J Heart Fail; 2004 Mar 15; 6(3):359-63. PubMed ID: 14987589
    [Abstract] [Full Text] [Related]

  • 6. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm.
    Bhardwaj A, Januzzi JL.
    Crit Pathw Cardiol; 2009 Dec 15; 8(4):146-50. PubMed ID: 19952548
    [Abstract] [Full Text] [Related]

  • 7. Updating the role of natriuretic peptide levels in cardiovascular disease.
    Gopal DJ, Iqbal MN, Maisel A.
    Postgrad Med; 2011 Nov 15; 123(6):102-13. PubMed ID: 22104459
    [Abstract] [Full Text] [Related]

  • 8. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure.
    Morello AM, Januzzi JL.
    Expert Rev Mol Diagn; 2006 Sep 15; 6(5):649-62. PubMed ID: 17009901
    [Abstract] [Full Text] [Related]

  • 9. Can B-type natriuretic peptides replace heart failure risk models?
    Levy WC.
    Eur J Heart Fail; 2008 Mar 15; 10(3):224-5. PubMed ID: 18313983
    [No Abstract] [Full Text] [Related]

  • 10. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
    Amir O, Paz H, Ammar R, Yaniv N, Schliamser JE, Lewis BS.
    Isr Med Assoc J; 2008 Feb 15; 10(2):109-12. PubMed ID: 18432021
    [Abstract] [Full Text] [Related]

  • 11. [Determination of brain natriuretic peptide levels and its N-terminal fragment for the evaluation of renal replacement therapies efficiency in patients with decompensated chronic heart failure].
    Tabak'ian EA, Zaruba AIu, Rogoza AN, Ataullakhanova DM, Kukharchuk VV.
    Ter Arkh; 2010 Feb 15; 82(8):24-9. PubMed ID: 20873241
    [Abstract] [Full Text] [Related]

  • 12. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Bhardwaj A, Rehman SU, Mohammed A, Baggish AL, Moore SA, Januzzi JL.
    Am Heart J; 2010 Apr 15; 159(4):532-538.e1. PubMed ID: 20362709
    [Abstract] [Full Text] [Related]

  • 13. Circulating natriuretic peptide levels in acute heart failure.
    Maisel A.
    Rev Cardiovasc Med; 2007 Apr 15; 8 Suppl 5():S13-21. PubMed ID: 18192949
    [Abstract] [Full Text] [Related]

  • 14. Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure.
    Masson S, Latini R.
    Am J Cardiol; 2008 Feb 04; 101(3A):56-60. PubMed ID: 18243860
    [Abstract] [Full Text] [Related]

  • 15. Natriuretic peptides in heart failure: their role in daily practice.
    Loboz-Grudzień K, Jaroch J.
    Cardiol J; 2009 Feb 04; 16(1):1-3. PubMed ID: 19130409
    [No Abstract] [Full Text] [Related]

  • 16. Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides?
    Daly MG, Frampton CM, Troughton RW.
    J Am Coll Cardiol; 2010 Feb 02; 55(5):451-3. PubMed ID: 20117458
    [No Abstract] [Full Text] [Related]

  • 17. Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide.
    Hülsmann M, Berger R, Mörtl D, Gore O, Meyer B, Pacher R.
    Eur J Heart Fail; 2005 Jun 02; 7(4):552-6. PubMed ID: 15921794
    [Abstract] [Full Text] [Related]

  • 18. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM, Green JA, Januzzi JL.
    Am J Ther; 2009 Jun 02; 16(2):171-7. PubMed ID: 19300043
    [Abstract] [Full Text] [Related]

  • 19. Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal pro-B-type natriuretic peptide measurement.
    Troughton RW, Richards AM.
    Am J Cardiol; 2008 Feb 04; 101(3A):72-5. PubMed ID: 18243863
    [Abstract] [Full Text] [Related]

  • 20. The clinical role of natriuretic peptides--importance of BNP and NT-proBNP. Implications in heart failure and acute coronary syndrome.
    Machado M, Falcão LM, Ravara L.
    Rev Port Cardiol; 2004 Feb 04; 23(7-8):1005-32. PubMed ID: 15478326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.